MSA
AVNS

Marino Stram & Associates’s Avanos Medical AVNS Stock Holding History

Marino Stram & Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-12
Closed -$1K – 478
2018
Q2 		$1K Hold
12
– – ﹤0.01% 425
2018
Q1 		$1K Hold
12
– – ﹤0.01% 438
2017
Q4 		$1K Buy
+12
New +$552 ﹤0.01% 443

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Marino Stram & Associates's AVNS Position: Q3 2018 in Review

Marino Stram & Associates sold out of Avanos Medical (AVNS) in Q3 2018, closing a stake of 12 shares — an estimated $1K sold.

Marino Stram & Associates first reported a position in AVNS in Q4 2017 and held it in 3 quarters. The position peaked at $1K in Q2 2018. 387 funds tracked by Wall St. Rank hold AVNS as of Q3 2018.

  • Marino Stram & Associates reported no remaining Avanos Medical position as of Q3 2018 after selling out during the quarter.
  • Marino Stram & Associates sold 12 Avanos Medical shares in Q3 2018, an estimated $1K.
  • Marino Stram & Associates first reported a position in Avanos Medical in Q4 2017 and held it in 3 quarters.
  • Marino Stram & Associates's Avanos Medical position peaked at $1K in Q2 2018.
  • 387 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2018.

Based on Marino Stram & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.